Who We Are

Aarden Pharmaceuticals is a drug discovery and development company, focused on creating novel treatments for disease by modulating a family of enzymes called protein tyrosine phosphatase. Our pipeline includes programs in tuberculosis, cancer and autoimmune disorders. 


Aarden’s novel technology, developed in the labs of the Indiana University School of Medicine, is a chemistry breakthrough that enables it to make drugs against a previously undruggable set of intracellular phosphatase (PTP) disease targets.
Aarden is led by a team of experienced scientists and drug developers, with the support of highly-regarded private investors and partners, including Indiana University.